Table 2.
Total |
Normal eGFR |
Decreased eGFR |
||||
---|---|---|---|---|---|---|
r | p value | r | p value | r | p value | |
PCSK9 | −0.039 | 0.079 | −0.038 | 0.190 | −0.054 | 0.109 |
Totalcholesterol | −0.035 | 0.110 | 0.002 | 0.938 | −0.025 | 0.450 |
Triglyceride | 0.043 | 0.062 | 0.043 | 0.139 | −0.005 | 0.880 |
LDL-C | −0.064 | 0.014 | −0.027 | 0.553 | −0.031 | 0.421 |
HDL-C | −0.082 | <0.001 | −0.069 | 0.295 | 0.020 | 0.560 |
Apolipoprotein A1 | −0.080 | <0.001 | −0.040 | 0.168 | −0.016 | 0.628 |
Apolipoprotein B | −0.080 | <0.001 | −0.038 | 0.182 | −0.045 | 0.178 |
Lipoprotein(a) | −0.057 | 0.179 | −0.034 | 0.234 | −0.015 | 0.655 |
Bold indicates statistical significance (p < 0.05). eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PCSK9, proprotein convertase subtilisin/kexin type 9.